These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
269 related articles for article (PubMed ID: 26552000)
1. Efficacy of parainfluenza virus 5 (PIV5)-based tuberculosis vaccines in mice. Chen Z; Gupta T; Xu P; Phan S; Pickar A; Yau W; Karls RK; Quinn FD; Sakamoto K; He B Vaccine; 2015 Dec; 33(51):7217-7224. PubMed ID: 26552000 [TBL] [Abstract][Full Text] [Related]
2. Sequential pulmonary immunization with heterologous recombinant influenza A virus tuberculosis vaccines protects against murine M. tuberculosis infection. Muflihah H; Flórido M; Lin LCW; Xia Y; Triccas JA; Stambas J; Britton WJ Vaccine; 2018 Apr; 36(18):2462-2470. PubMed ID: 29602704 [TBL] [Abstract][Full Text] [Related]
3. Gene-based neonatal immune priming potentiates a mucosal adenoviral vaccine encoding mycobacterial Ag85B. Dai G; Rady HF; Huang W; Shellito JE; Mason C; Ramsay AJ Vaccine; 2016 Dec; 34(50):6267-6275. PubMed ID: 27823900 [TBL] [Abstract][Full Text] [Related]
4. MVA.85A boosting of BCG and an attenuated, phoP deficient M. tuberculosis vaccine both show protective efficacy against tuberculosis in rhesus macaques. Verreck FA; Vervenne RA; Kondova I; van Kralingen KW; Remarque EJ; Braskamp G; van der Werff NM; Kersbergen A; Ottenhoff TH; Heidt PJ; Gilbert SC; Gicquel B; Hill AV; Martin C; McShane H; Thomas AW PLoS One; 2009; 4(4):e5264. PubMed ID: 19367339 [TBL] [Abstract][Full Text] [Related]
5. Performance of Homologous and Heterologous Prime-Boost Immunization Regimens of Recombinant Adenovirus and Modified Vaccinia Virus Ankara Expressing an Ag85B-TB10.4 Fusion Protein against Kou Y; Wan M; Shi W; Liu J; Zhao Z; Xu Y; Wei W; Sun B; Gao F; Cai L; Jiang C J Microbiol Biotechnol; 2018 Jun; 28(6):1022-1029. PubMed ID: 29847865 [TBL] [Abstract][Full Text] [Related]
6. Improvement of BCG protective efficacy with a novel chimpanzee adenovirus and a modified vaccinia Ankara virus both expressing Ag85A. Stylianou E; Griffiths KL; Poyntz HC; Harrington-Kandt R; Dicks MD; Stockdale L; Betts G; McShane H Vaccine; 2015 Nov; 33(48):6800-8. PubMed ID: 26478198 [TBL] [Abstract][Full Text] [Related]
7. Immunogenicity and protective efficacy of a fusion protein vaccine consisting of antigen Ag85B and HspX against Mycobacterium tuberculosis infection in mice. Li Q; Yu H; Zhang Y; Wang B; Jiang W; Da Z; Xian Q; Wang Y; Liu X; Zhu B Scand J Immunol; 2011 Jun; 73(6):568-76. PubMed ID: 21323695 [TBL] [Abstract][Full Text] [Related]
8. Recombinant bacille Calmette-Guerin coexpressing Ag85b, CFP10, and interleukin-12 elicits effective protection against Mycobacterium tuberculosis. Chen YY; Lin CW; Huang WF; Chang JR; Su IJ; Hsu CH; Cheng HY; Hsu SC; Dou HY J Microbiol Immunol Infect; 2017 Feb; 50(1):90-96. PubMed ID: 25732698 [TBL] [Abstract][Full Text] [Related]
9. Using a prime and pull approach, lentivector vaccines expressing Ag85A induce immunogenicity but fail to induce protection against Mycobacterium bovis bacillus Calmette-Guérin challenge in mice. Britton G; MacDonald DC; Brown JS; Collins MK; Goodman AL Immunology; 2015 Oct; 146(2):264-70. PubMed ID: 26095282 [TBL] [Abstract][Full Text] [Related]
10. Goats primed with Mycobacterium bovis BCG and boosted with a recombinant adenovirus expressing Ag85A show enhanced protection against tuberculosis. Pérez de Val B; Villarreal-Ramos B; Nofrarías M; López-Soria S; Romera N; Singh M; Abad FX; Xing Z; Vordermeier HM; Domingo M Clin Vaccine Immunol; 2012 Sep; 19(9):1339-47. PubMed ID: 22761299 [TBL] [Abstract][Full Text] [Related]
11. A live attenuated BCG vaccine overexpressing multistage antigens Ag85B and HspX provides superior protection against Mycobacterium tuberculosis infection. Yuan X; Teng X; Jing Y; Ma J; Tian M; Yu Q; Zhou L; Wang R; Wang W; Li L; Fan X Appl Microbiol Biotechnol; 2015 Dec; 99(24):10587-95. PubMed ID: 26363555 [TBL] [Abstract][Full Text] [Related]
12. [Novel vaccines against M. tuberculosis]. Okada M Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920 [TBL] [Abstract][Full Text] [Related]
13. Prime-boost bacillus Calmette-Guérin vaccination with lentivirus-vectored and DNA-based vaccines expressing antigens Ag85B and Rv3425 improves protective efficacy against Mycobacterium tuberculosis in mice. Xu Y; Yang E; Wang J; Li R; Li G; Liu G; Song N; Huang Q; Kong C; Wang H Immunology; 2014 Oct; 143(2):277-86. PubMed ID: 24773322 [TBL] [Abstract][Full Text] [Related]
14. Recombinant Ag85B vaccine by taking advantage of characteristics of human parainfluenza type 2 virus vector showed Mycobacteria-specific immune responses by intranasal immunization. Watanabe K; Matsubara A; Kawano M; Mizuno S; Okamura T; Tsujimura Y; Inada H; Nosaka T; Matsuo K; Yasutomi Y Vaccine; 2014 Mar; 32(15):1727-35. PubMed ID: 24486310 [TBL] [Abstract][Full Text] [Related]
15. Recombinant BCG coexpressing Ag85B, ESAT-6 and mouse-IFN-gamma confers effective protection against Mycobacterium tuberculosis in C57BL/6 mice. Xu Y; Zhu B; Wang Q; Chen J; Qie Y; Wang J; Wang H; Wang B; Wang H FEMS Immunol Med Microbiol; 2007 Dec; 51(3):480-7. PubMed ID: 17919299 [TBL] [Abstract][Full Text] [Related]
16. Immunogenicity and protective efficacy conferred by a novel recombinant Mycobacterium bovis bacillus Calmette-Guérin strain expressing interleukin-12p70 of human cytokine and Ag85A of Mycobacterium tuberculosis fusion protein. Deng YH; He HY; Zhang FJ Scand J Immunol; 2013 Dec; 78(6):497-506. PubMed ID: 24283772 [TBL] [Abstract][Full Text] [Related]
17. The immunity and protective effects of antigen 85A and heat-shock protein X against progressive tuberculosis. Jeon BY; Kim SC; Eum SY; Cho SN Microbes Infect; 2011 Mar; 13(3):284-90. PubMed ID: 21093603 [TBL] [Abstract][Full Text] [Related]
18. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine expressing a fusion protein of Ag85B-Esat6-HspX in mice. Yuan W; Dong N; Zhang L; Liu J; Lin S; Xiang Z; Qiao H; Tong W; Qin C Vaccine; 2012 Mar; 30(14):2490-7. PubMed ID: 21704108 [TBL] [Abstract][Full Text] [Related]
19. Protective immune responses to a recombinant adenovirus type 35 tuberculosis vaccine in two mouse strains: CD4 and CD8 T-cell epitope mapping and role of gamma interferon. Radosevic K; Wieland CW; Rodriguez A; Weverling GJ; Mintardjo R; Gillissen G; Vogels R; Skeiky YA; Hone DM; Sadoff JC; van der Poll T; Havenga M; Goudsmit J Infect Immun; 2007 Aug; 75(8):4105-15. PubMed ID: 17526747 [TBL] [Abstract][Full Text] [Related]